Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | ALPL | P05186 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 2/20 | 0.37 |
| ▸ | SRC | P12931 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30020861 | 0.81 | CYP1A2 (0.50) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL31021896 | 0.81 | CYP1A2 (0.49) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL17362802 | 0.80 | CYP1A2 (0.49) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL3338566 | 0.77 | CYP1A2 (0.52) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL20645712 | 0.75 | CYP1A2 (0.50) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL16652940 | 0.74 | GAA (0.66) | CYP1A2GLAGAAKDM4EPDE3B | |
| SCHEMBL20645713 | 0.74 | CYP1A2 (0.49) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL16115046 | 0.74 | XDH (0.51) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL19332337 | 0.72 | CYP1A2 (0.44) | CYP1A2GLAGAAKDM4EXDH | |
| SCHEMBL14743565 | 0.72 | CYP1A2 (0.44) | CYP1A2GLAGAAKDM4EXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022222871-A1 | HETEROCYCLIC COMPOUNDS AS KRAS G12C INHIBITORS | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2022-10-27 | — | — | WO | disclosed |